{"id":"W3203740018","doi":"10.1183/23120541.00465-2021","title":"Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma","year":2021,"lang":"en","type":"article","venue":"ERJ Open Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Memorial University of Newfoundland; Impact; Université de Montréal; AstraZeneca (Canada)","funders":"AstraZeneca Canada","keywords":"Benralizumab; Medicine; Discontinuation; Asthma; Mepolizumab; Intensive care medicine; Dermatology; Internal medicine; Eosinophil","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003989844,0.00007339222,0.0002029922,0.0002367403,0.00008636548,0.00004976587,0.0001797677,0.00005368206,0.0007867215],"category_scores_gemma":[0.0002703604,0.00005546493,0.00002571497,0.0006531926,0.00009355888,0.0001528684,0.0001287404,0.0002148229,0.000035346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001919241,"about_ca_system_score_gemma":0.0026504,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08703368,"about_ca_topic_score_gemma":0.3315837,"domain_scores_codex":[0.9984261,0.0002033588,0.0001770624,0.0002437674,0.0005657063,0.0003840184],"domain_scores_gemma":[0.9986984,0.00004702323,0.00002827675,0.0003225899,0.0005594636,0.0003442562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003821556,0.0004314102,0.9743454,0.000058627,0.00001844431,0.0002638484,0.0002768804,0.00000727895,0.0001214456,0.000324482,0.001773481,0.02199657],"study_design_scores_gemma":[0.00229785,0.0004574068,0.9810967,0.0002703604,0.00000461678,0.000005062553,0.0004449858,0.00001967546,0.0006120327,0.00003597944,0.01468231,0.00007299949],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760467,0.0001676885,5.582894e-7,0.001022819,0.00001995876,0.0007662714,0.00004114702,0.000002924137,0.02193197],"genre_scores_gemma":[0.9965546,0.000006354362,0.00008111735,0.00009942679,0.00002746611,0.00003765651,0.0001499969,0.00001490233,0.003028453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.24455,"threshold_uncertainty_score":0.9190459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04336339213837876,"score_gpt":0.3654549756443375,"score_spread":0.3220915835059587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}